These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 4599277)

  • 1. [Trial of L-dopa as hypotensive medication in arterial hypertension. Preliminary report].
    Torres Zamora M; García Monterd G; Chávez Domínguez R; Chávez Lara B; Serrano PA
    Arch Inst Cardiol Mex; 1974; 44(2):267-74. PubMed ID: 4599277
    [No Abstract]   [Full Text] [Related]  

  • 2. Pindolol: a comparison with other antihypertensive drugs and a double-blind placebo trial.
    Waal-Manning HJ; Simpson FO
    N Z Med J; 1974 Aug; 80(522):151-7. PubMed ID: 4608769
    [No Abstract]   [Full Text] [Related]  

  • 3. Propranolol therapy in essential hypertension. Observations on predictability of therapeutic response.
    Hansson L; Zweifler AJ; Julius S; Ellis CN
    Int J Clin Pharmacol; 1974 Sep; 10(2):79-89. PubMed ID: 4448555
    [No Abstract]   [Full Text] [Related]  

  • 4. Pindolol, (Visken, LB46). A new treatment for hypertension: report of a multicentric open study.
    Collins IS; King IW
    Curr Ther Res Clin Exp; 1972 Apr; 14(4):185-94. PubMed ID: 4402011
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effect of a decarboxylase inhibitor (Ro 4-4602) in combination with L-dopa on inhibited depressions].
    Matussek N; Benkert O; Schneider K; Otten H; Pohlmeier H
    Arzneimittelforschung; 1970 Jul; 20(7):934-5. PubMed ID: 4918921
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of 'responders' to long-term pindolol therapy from phasic changes in cardiovascular function during acute intravenous administration in essential hypertension.
    Logan AG; Milne BJ; Colman JM
    Clin Invest Med; 1978; 1(3-4):147-52. PubMed ID: 42504
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of clonidin and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients.
    Sung PK; Samet P; Yeh BK
    Curr Ther Res Clin Exp; 1971 May; 13(5):280-5. PubMed ID: 4998390
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of metolazone in the long-term treatment of essential hypertension.
    Cangiano JL; Campos JA; Trevino A; Ramirez-Gonzalez R; Ramirez-Muzo O
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):778-85. PubMed ID: 4217244
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison between alprenolol and chlorthalidone as antihypertensive agents.
    Bengtsson C
    Acta Med Scand; 1972 May; 191(5):433-9. PubMed ID: 4555618
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension.
    Aybak M; Sermet A; Ayyildiz MO; Karakilçik AZ
    Arzneimittelforschung; 1995 Dec; 45(12):1271-3. PubMed ID: 8595083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practolol-propranolol. A comparison of antihypertensive effect.
    Andersson O; Berglund G
    Acta Med Scand; 1974 Dec; 196(6):479-82. PubMed ID: 4617491
    [No Abstract]   [Full Text] [Related]  

  • 12. [Urapidil in primary arterial hypertension].
    Román O; Sudy E; Gac JC; Valenzuela MA
    Rev Med Chil; 1987 Jul; 115(7):648-54. PubMed ID: 3331026
    [No Abstract]   [Full Text] [Related]  

  • 13. Circulatory effects of fenfluramine in obese hypertensive patients.
    Mroczek WJ; Lee WR; Finnerty FA
    Curr Ther Res Clin Exp; 1974 Nov; 16(11):1197-202. PubMed ID: 4214654
    [No Abstract]   [Full Text] [Related]  

  • 14. Paroxysmal hypertension during L-dopa treatment in parkinsonism: a metabolic error or a pharmacological effect?
    Barjon P; Fourcade J; Mimran A; Charra B
    Rev Eur Etud Clin Biol; 1972 Feb; 17(2):187-92. PubMed ID: 5055013
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative double-blind, crossover and randomized study of the antihypertensive activity of nifedipine in primary arterial hypertension].
    de Mendonça JV; de Castro Filho J
    Arq Bras Cardiol; 1984 Sep; 43(3):219-22. PubMed ID: 6398995
    [No Abstract]   [Full Text] [Related]  

  • 16. [Acute effects of bethanidine on arterial pressure and on urinary excretion of catecholamines in patients with essential hypertension].
    Fabris F; Mathis I; Rappelli A; Gagna C
    Boll Soc Ital Biol Sper; 1968 Feb; 44(4):320-4. PubMed ID: 5677880
    [No Abstract]   [Full Text] [Related]  

  • 17. Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients.
    de Champlain J; Karas M; Nguyen P; Cartier P; Wistaff R; Toal CB; Nadeau R; Larochelle P
    J Hypertens; 1998 Sep; 16(9):1357-69. PubMed ID: 9746123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of idiopathic arterial hypertension with delayed-action nifedipine].
    Liszewska-Pfejfer D; Jankowski K; Kraska T
    Pol Tyg Lek; 1988 Jul; 43(27):872-5. PubMed ID: 3072536
    [No Abstract]   [Full Text] [Related]  

  • 19. Catecholamines and heart function in heart transplant patients: effects of beta1- versus nonselective beta-blockade.
    Leenen FH; Davies RA; Fourney A
    Clin Pharmacol Ther; 1998 Nov; 64(5):522-35. PubMed ID: 9834044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of diazepam on arterial blood pressure behavior and urinary elimination of epinephrine and norepinephrine under stress conditions in stabilized essential hypertension].
    D'Amelio G; Dalla Volta S; Celon E
    Minerva Med; 1974 Jun; 65(45):2459-62. PubMed ID: 4845655
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.